Showing 611-620 of 2320 results for "".
Primary Care Providers as Allies in Dermatology
https://practicaldermatology.com/topics/practice-management/primary-care-providers-as-allies-in-dermatology/21117/In light of a dermatology workforce shortage, PCPs see a majority of skin-related cases. Dermatologists can work with them to improve patient care.A Peak Inside the Psoriasis Pipeline
https://practicaldermatology.com/columns/clinical-focus-1/special-edition-what-i-did-on-my-summer-vacation/23803/Here’s a look at what’s here today and what is coming down the pike for psoriasis patients.Scientifically Speaking: Rox Anderson, MD Talks Changing Lives Through Inventions
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-rox-anderson-md-talks-changing-lives-through-inventions/20140/Rox Anderson, MD has been at the forefront of inventions that have shaped the modern practice of dermatology. He discusses his inspirations and his desire to advance patient care. Host Joel L. Cohen, MD talks to him about his latest innovations and a recent recognition.Melanoma in Skin of Color: More to Learn
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-in-skin-of-color-more-to-learn/23486/With evidence showing that cumulative UV exposure is not strongly correlated with melanoma risk in patients with skin of color, dermatologists must re-consider their messaging.Skin Cancer Perceptions, Cimzia for Psoriasis, Eczema and CV Risk
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-skin-cancer-perceptions-cimzia-for-psoriasis-eczema-and-cv-risk/18301/A new national survey, Skin Cancer In America 2018, conducted by Health Union, explores perceptions of patients with skin cancer. Cimzia (certolizumab pegol, UCB) has received FDA approval for treatment of adults with moderate to severe plaque psoriasis. Cimzia is the first Fc-free, PEGylated anti TSolving the Keloid Conundrum
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/solving-the-keloid-conundrum/20488/Are cosmetic treatments too risky for patients prone to keloids?Radiesse Plus Launches, AAD Convenes, NPF Registry Begins
https://practicaldermatology.com/topics/psoriasis/dermwiretv-radiesse-plus-launches-aad-convenes-npf-registry-begins--epesurag/18939/In this edition of DermWireTV: Merz Aesthetics launches Radiesse Plus with lidocaine for the treatment of facial wrinkles and folds and the National Psoriasis Foundation (NPF) launches new patient registry focused on patient safety. Plus, updates from the annual meeting of the American Academy of DeBreaking the Itch-Scratch Cycle
https://practicaldermatology.com/topics/atopic-dermatitis/breaking-the-itch-scratch-cycle/23922/Upadacitinib’s rapid relief for patients with moderate-to-severe atopic dermatitis.Energy-Based Devices You Should Have On Your Radar
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/energy-based-devices-you-should-have-on-your-radar/23646/Here’s a look at technologies that may play a key role in patient management this year and beyond.Atopic Dermatitis: A Review of Common Comorbidities
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-a-review-of-common-comorbidities/23352/It is important to acknowledge and identify comorbidities to successfully manage AD and improve patient quality of life.